These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10063913)

  • 1. Evaluation of effects of ethyl alcohol and bismuth subsalicylate on gastric mucosal barrier in man.
    Dy RM; Lof J; DiBaise JK; Quigley EM
    Dig Dis Sci; 1999 Feb; 44(2):286-9. PubMed ID: 10063913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoprotective effect of bismuth subsalicylate in indomethacin-treated rats is associated with enhanced mucus bismuth concentration.
    Tanaka S; Guth PH; Carryl OR; Kaunitz JD
    Aliment Pharmacol Ther; 1997 Jun; 11(3):605-12. PubMed ID: 9218090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The gastroduodenal mucus barrier and its role in protection against luminal pepsins: the effect of 16,16 dimethyl prostaglandin E2, carbopol-polyacrylate, sucralfate and bismuth subsalicylate.
    Copeman M; Matuz J; Leonard AJ; Pearson JP; Dettmar PW; Allen A
    J Gastroenterol Hepatol; 1994; 9 Suppl 1():S55-9. PubMed ID: 7881020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stress, diet and alcohol-induced oxidative gastrointestinal mucosal injury in rats and protection by bismuth subsalicylate.
    Bagchi D; Carryl OR; Tran MX; Krohn RL; Bagchi DJ; Garg A; Bagchi M; Mitra S; Stohs SJ
    J Appl Toxicol; 1998; 18(1):3-13. PubMed ID: 9526828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of gastroprotection by bismuth subsalicylate against chemically induced oxidative stress in cultured human gastric mucosal cells.
    Bagchi D; McGinn TR; Ye X; Balmoori J; Bagchi M; Stohs SJ; Kuszynski CA; Carryl OR; Mitra S
    Dig Dis Sci; 1999 Dec; 44(12):2419-28. PubMed ID: 10630491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of an ammonia electrode for rapid quantification of Helicobacter pylori urease: its use in the endoscopy room and in the assessment of urease inhibition by bismuth subsalicylate.
    Butcher GP; Ryder SD; Hughes SJ; Stewart M; Bird N; Haqqani MT; Rhodes JM
    Digestion; 1992; 53(3-4):142-8. PubMed ID: 1291402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of aluminum hydroxide/magnesium hydroxide antacid and bismuth subsalicylate on gastric pH in horses.
    Clark CK; Merritt AM; Burrow JA; Steible CK
    J Am Vet Med Assoc; 1996 May; 208(10):1687-91. PubMed ID: 8641951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastroduodenal mucosal prostaglandin generation in patients with Helicobacter pylori before and after treatment with bismuth subsalicylate.
    Avunduk C; Suliman M; Gang D; Polakowski N; Eastwood GL
    Dig Dis Sci; 1991 Apr; 36(4):431-4. PubMed ID: 2007360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced tetracycline bioavailability caused by magnesium aluminum silicate in liquid formulations of bismuth subsalicylate.
    Healy DP; Dansereau RJ; Dunn AB; Clendening CE; Mounts AW; Deepe GS
    Ann Pharmacother; 1997 Dec; 31(12):1460-4. PubMed ID: 9416381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of antimicrobial activity of zinc chloride and bismuth subsalicylate against clinical isolates of Helicobacter pylori.
    Yakoob J; Abbas Z; Usman MW; Awan S; Naz S; Jafri F; Hamid S; Jafri W
    Microb Drug Resist; 2014 Aug; 20(4):305-9. PubMed ID: 23844851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro synergy testing of clarithromycin and 14-hydroxyclarithromycin with amoxicillin or bismuth subsalicylate against Helicobacter pylori.
    Meyer JM; Ryu S; Pendland SL; Danziger LH
    Antimicrob Agents Chemother; 1997 Jul; 41(7):1607-8. PubMed ID: 9210696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bismuth subsalicylate markedly decreases hydrogen sulfide release in the human colon.
    Suarez FL; Furne JK; Springfield J; Levitt MD
    Gastroenterology; 1998 May; 114(5):923-9. PubMed ID: 9558280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of pepper and bismuth subsalicylate on gastric pain and surface hydrophobicity in the rat.
    Lichtenberger LM; Romero JJ; Carryl OR; Illich PA; Walters ET
    Aliment Pharmacol Ther; 1998 May; 12(5):483-90. PubMed ID: 9663730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of bismuth and nitecapone on acetaldehyde production by Helicobacter pylori.
    Salmela KS; Roine RP; Höök-Nikanne J; Kosunen TU; Salaspuro M
    Scand J Gastroenterol; 1994 Jun; 29(6):528-31. PubMed ID: 8079111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bismuth subsalicylate increases intracellular Ca2+, MAP-kinase activity, and cell proliferation in normal human gastric mucous epithelial cells.
    Gilster J; Bacon K; Marlink K; Sheppard B; Deveney C; Rutten M
    Dig Dis Sci; 2004 Mar; 49(3):370-8. PubMed ID: 15139483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of bismuth-containing compounds.
    Lambert JR
    Rev Infect Dis; 1991; 13 Suppl 8():S691-5. PubMed ID: 1925310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bismuth subsalicylate in the treatment of gastritis due to Campylobacter pylori.
    McNulty CA
    Rev Infect Dis; 1990; 12 Suppl 1():S94-8. PubMed ID: 2406863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bismuth subsalicylate in the treatment of H2 blocker resistant duodenal ulcers: role of Helicobacter pylori.
    Wagner S; Gebel M; Haruma K; Bär W; Lange P; Freise J; Gladziwa U; Schmidt FW
    Gut; 1992 Feb; 33(2):179-83. PubMed ID: 1347278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of bismuth subsalicylate on ciprofloxacin bioavailability.
    Rambout L; Sahai J; Gallicano K; Oliveras L; Garber G
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2187-90. PubMed ID: 7811043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of one-day oral dosing with three bismuth compounds for the suppression of Helicobacter pylori assessed by the 13C-urea breath test.
    Prewett EJ; Luk YW; Fraser AG; Lam WM; Pounder RE
    Aliment Pharmacol Ther; 1992 Feb; 6(1):97-102. PubMed ID: 1543820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.